TP53 and Li-Fraumeni syndrome: An analysis of patients with Li-Fraumeni syndrome, which carry p53 germline mutations, showed that patients with missense p53 mutations had on average a 9-year earlier cancer onset than patients with other types of p53 mutations, such as splicing mutations, non-sense mutations, or frameshift deletions/insertions [79].